ANTG joins over-the-counter race with IBS clinical trial by Steve Jones June 14, 2023June 15, 2023 Australian Natural Therapeutics Group (ANTG) has partnered with research firm SVG Pharmaceuticals in a bid to […]
ANTG subsidiary fined for alleged security ‘failures’ at cultivation site by Steve Jones June 13, 2023June 15, 2023
Company news: Asterion; Ecofibre; Avecho; Epsilon Healthcare; Creso Pharma; Cann Global by Martin Lane and Steve Jones May 18, 2023May 18, 2023
Clinical trial to study impact of cannabis on endometriosis by Steve Jones April 19, 2023April 19, 2023
Local industry pays tribute to ‘father of cannabis research’ Professor Raphael Mechoulam by Martin Lane March 15, 2023March 15, 2023
Asterion’s Australian vision in tatters as firm goes into liquidation by Steve Jones February 8, 2023February 8, 2023
ANTG to ramp up manufacturing with acquisition of Brisbane facility by Steve Jones December 19, 2022December 20, 2022
Cannatrek quits AMCA after facing suspension for alleged advertising breaches by Steve Jones October 13, 2022October 18, 2022
Company news: ANTG; MGC Pharma; Medlab Clinical; Bod; Creso Pharma; InhaleRx; Incannex by Martin Lane August 4, 2022August 4, 2022
